Mary Reumuth, CHIEF FINANCIAL OFFICER at Kala Pharmaceuticals, Inc. (KALA), sold 2,613 shares at $0.37 ($967) on 2022-06-27, disclosed to the SEC on 2022-06-29.
Scheduled sale ($967) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KALA | SELL | 2025-06-04 | $11K | — | Filing → |
| KALA | SELL | 2025-01-07 | $13K | — | Filing → |
| KALA | SELL | 2024-06-27 | $20K | — | Filing → |